Zkusit zdarma
Natera, Inc.

Natera, Inc.

NTRA
Cena:
$ 203.19
-0.50 (-0.25%)
Valuace
100
Růst
70
Zdraví
71
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology

Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology

17:05 21-05-2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr...

Natera's EXPAND Trial Enrollment Crosses 2,000 Patient Milestone

Natera's EXPAND Trial Enrollment Crosses 2,000 Patient Milestone

13:31 21-05-2026

NTRA's EXPAND trial for Fetal Focus single-gene NIPT tops 2,000 patients, doubling in a year as new ...

Natera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the World

Natera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the World

7:00 21-05-2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr...

EXPAND Trial of Natera's Fetal Focus™ Single-Gene NIPT Surpasses >2,000 Patients Enrolled

EXPAND Trial of Natera's Fetal Focus™ Single-Gene NIPT Surpasses >2,000 Patients Enrolled

7:00 20-05-2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA...

NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer

NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer

11:50 18-05-2026

Natera wins FDA approval for Signatera CDx in bladder cancer, marking the first blood-based MRD comp...

Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)

Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)

12:45 15-05-2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr...

Natera Q1 Earnings Call Highlights

Natera Q1 Earnings Call Highlights

16:08 08-05-2026

Natera NASDAQ: NTRA reported first-quarter 2026 revenue of $697 million, up 39% year over year, as t...

Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates

Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates

20:11 07-05-2026

Natera (NTRA) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate ...

Natera, Inc. (NTRA) Q1 2026 Earnings Call Transcript

Natera, Inc. (NTRA) Q1 2026 Earnings Call Transcript

20:11 07-05-2026

Natera, Inc. (NTRA) Q1 2026 Earnings Call Transcript...

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

20:00 07-05-2026

While the top- and bottom-line numbers for Natera (NTRA) give a sense of how the business performed ...

Natera Reports First Quarter 2026 Financial Results

Natera Reports First Quarter 2026 Financial Results

16:05 07-05-2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and ge...

Merit Financial Group LLC Buys 4,610 Shares of Natera, Inc. $NTRA

Merit Financial Group LLC Buys 4,610 Shares of Natera, Inc. $NTRA

6:00 20-04-2026

Merit Financial Group LLC lifted its stake in Natera, Inc. (NASDAQ: NTRA) by 32.7% in the fourth qua...

Natera, Inc. $NTRA Shares Sold by Mirae Asset Global Investments Co. Ltd.

Natera, Inc. $NTRA Shares Sold by Mirae Asset Global Investments Co. Ltd.

5:18 20-04-2026

Mirae Asset Global Investments Co. Ltd. reduced its stake in Natera, Inc. (NASDAQ: NTRA) by 21.4% in...

Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst

Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst

14:30 14-04-2026

William Blair initiated coverage on Natera Inc. (NASDAQ:NTRA), highlighting the company's strong pos...

Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics' MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma

Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics' MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma

8:00 13-04-2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr...

Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents

Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents

6:00 09-04-2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr...

3,949 Shares in Natera, Inc. $NTRA Acquired by Azzad Asset Management Inc. ADV

3,949 Shares in Natera, Inc. $NTRA Acquired by Azzad Asset Management Inc. ADV

3:32 08-04-2026

Azzad Asset Management Inc. ADV bought a new position in shares of Natera, Inc. (NASDAQ: NTRA) in th...

20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera's Oncology Platform

20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera's Oncology Platform

6:00 07-04-2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA and pre...

Exchange Traded Concepts LLC Sells 2,945 Shares of Natera, Inc. $NTRA

Exchange Traded Concepts LLC Sells 2,945 Shares of Natera, Inc. $NTRA

3:52 04-04-2026

Exchange Traded Concepts LLC lessened its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 40.4%...

Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery

Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery

12:48 31-03-2026

Natera stock is showing exceptional strength. What's fueling NTRA momentum?...

close

NATERA LAUNCHES EDEN STUDY ON EARLY RISK ASSESSMENT FOR PREECLAMPSIA AND ADVERSE PREGNANCY OUTCOMES

06-02-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA SUBMITS SIGNATERA™ CDX PMA TO FDA

02-02-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA ANNOUNCES COMPLETION OF ENROLLMENT IN RANDOMIZED ACES-EMB TRIAL IN HEART TRANSPLANTATION

28-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

PROSPERA™ FEATURED IN LANDMARK INTERVENTIONAL STUDY ADVANCING LUNG TRANSPLANT CARE

26-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA PUBLISHES CLINICAL VALIDATION OF LATITUDE™ TISSUE-FREE MRD TEST IN COLORECTAL CANCER

21-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA'S FETAL FOCUS™ SINGLE GENE NIPT (SGNIPT) SELECTED FOR PRESTIGIOUS ORAL PLENARY PRESENTATION AT SOCIETY OF MATERNAL FETAL MEDICINE (SMFM) MEETING

20-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA ANNOUNCES NEXT BREAKTHROUGH IN MRD-BASED RISK STRATIFICATION, LEVERAGING MULTI-MODAL AI MODELING

13-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA (CFDNA...
Více zde

NATERA TO SCALE AI FOUNDATION MODELS IN PRECISION MEDICINE WITH NVIDIA

12-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ:NTRA), A GLOBAL LEADER IN CELL-FREE DNA TESTING...
Více zde

NATERA ANNOUNCES STRONG PRELIMINARY FOURTH QUARTER AND 2025 FINANCIAL RESULTS DRIVEN BY RECORD SIGNATERA™ GROWTH

11-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

EXELIXIS AND NATERA TO COLLABORATE ON STELLAR-316, A PHASE 3 PIVOTAL TRIAL OF ZANZALINTINIB FOR PATIENTS WITH COLORECTAL CANCER

07-01-2026
ALAMEDA, CALIF. & AUSTIN, TEXAS--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) AND NATERA (NASDAQ: ...
Více zde

NATERA PRESENTS UPDATED ANALYSES FROM ALTAIR CLINICAL TRIAL AT ASCO GI

05-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA LAUNCHES 21-GENE FETAL FOCUS™ SINGLE-GENE NIPT, POWERED BY ULTRA-SENSITIVE LINKEDSNP™ TECHNOLOGY

05-01-2026
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA TO PARTICIPATE IN THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

22-12-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA ANNOUNCES PUBLICATION OF SIGNATERA™ ANALYSIS FROM RANDOMIZED, PHASE III CALGB (ALLIANCE)/SWOG 80702 STUDY IN COLORECTAL CANCER

18-12-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

I-SPY 2 PUBLICATION IN NATURE COMMUNICATIONS SHOWS SIGNATERA™ CAN PREDICT TREATMENT RESPONSE AND RECURRENCE RISK IN EARLY-STAGE BREAST CANCER

16-12-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA AND MEDSIR TO COLLABORATE ON THE MIRADOR TRIAL IN BREAST CANCER

12-12-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

PHASE III PALLAS STUDY SHOWS SIGNATERA™ MRD TESTING PROVIDES POWERFUL POST‑SURGICAL PROGNOSTIC INFORMATION IN PATIENTS WITH HIGH AND INTERMEDIATE RISK HR+/HER2‑ BREAST CANCER

10-12-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA HIGHLIGHTS NEW FINDINGS IN LYMPHOMA AT THE ASH ANNUAL MEETING

09-12-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA ACQUIRES FORESIGHT DIAGNOSTICS

05-12-2025
AUSTIN, TEXAS & BOULDER, COLO.--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CEL...
Více zde

NEW SIGNATERA™ DATA IN LYMPHOMA AND MULTIPLE MYELOMA TO BE PRESENTED AT THE 2025 AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING

03-12-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA TO PRESENT 12 DATASETS INCLUDING >50,000 PATIENTS FEATURING SIGNATERA™ AT THE SAN ANTONIO BREAST CANCER SYMPOSIUM

02-12-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

EMPLOYEES VOLUNTEER OVER 1,500 HOURS DURING NATERA'S ANNUAL VOLUNTEER MONTH

19-11-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA INTEGRATES WITH FLATIRON HEALTH'S ONCOEMR® PLATFORM

12-11-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

06-11-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA ANNOUNCES EXPANSION TO 20 GENES FOR ITS FETAL FOCUS™ SINGLE-GENE NIPT

31-10-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA (CFDNA...
Více zde

NATERA TO REPORT ITS THIRD QUARTER RESULTS ON NOVEMBER 6, 2025

30-10-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA REPORTS STRONG ADVANCED ADENOMA DATA FROM PROSPECTIVE PROCEED-CRC TRIAL, DEMONSTRATING 22.5% SENSITIVITY AND 91.5% SPECIFICITY

28-10-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

HALPER SADEH LLC ENCOURAGES NATERA INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

27-10-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER C...
Více zde

SUCCESSFUL IMVIGOR011 TRIAL ACHIEVES 41% IMPROVEMENT IN OVERALL SURVIVAL FOR BLADDER CANCER PATIENTS

20-10-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

NATERA NAMED TO FAST COMPANY'S NEXT BIG THINGS IN TECH LIST

16-10-2025
AUSTIN, TEXAS--(BUSINESS WIRE)--NATERA, INC. (NASDAQ: NTRA), A GLOBAL LEADER IN CELL-FREE DNA AND PR...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-12-05 00:00:008-KStáhnout
2025-11-07 00:00:0010-QStáhnout
2025-11-06 00:00:008-KStáhnout
2025-08-08 01:00:0010-QStáhnout
2025-08-08 00:00:0010-QStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 00:00:008-KStáhnout
2025-06-18 01:00:008-KStáhnout
2025-06-18 00:00:008-KStáhnout
2025-05-09 01:00:0010-QStáhnout
2025-05-09 00:00:0010-QStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 00:00:008-KStáhnout
2025-03-12 00:00:008-KStáhnout
2025-03-11 23:00:008-KStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-12-06 00:00:008-KStáhnout
2024-12-05 23:00:008-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-08-09 01:00:0010-QStáhnout
2024-08-09 00:00:0010-QStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 00:00:008-KStáhnout
2024-07-22 01:00:008-KStáhnout
2024-07-22 00:00:008-KStáhnout
2024-06-18 01:00:008-KStáhnout
2024-06-18 00:00:008-KStáhnout
2024-05-10 01:00:0010-QStáhnout
2024-05-10 00:00:0010-QStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 00:00:008-KStáhnout
2024-02-29 00:00:0010-KStáhnout
2024-02-28 23:00:0010-KStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-01-22 00:00:008-KStáhnout
2024-01-21 23:00:008-KStáhnout
2024-01-09 00:00:008-KStáhnout
2024-01-08 23:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-07 23:00:008-KStáhnout
2023-09-07 01:00:008-KStáhnout
2023-09-07 00:00:008-KStáhnout
2023-08-04 01:00:0010-QStáhnout
2023-08-04 00:00:0010-QStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 00:00:008-KStáhnout
2023-06-15 01:00:008-KStáhnout
2023-06-15 00:00:008-KStáhnout
2023-05-10 01:00:0010-QStáhnout
2023-05-10 00:00:0010-QStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 00:00:008-KStáhnout
2023-04-21 01:00:008-KStáhnout
2023-04-21 00:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-03-01 00:00:0010-KStáhnout
2023-02-28 23:00:0010-KStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-22 23:00:008-KStáhnout
2022-11-16 00:00:008-KStáhnout
2022-11-15 23:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-07 23:00:008-KStáhnout
2022-08-15 01:00:008-KStáhnout
2022-08-15 00:00:008-KStáhnout
2022-08-05 01:00:0010-QStáhnout
2022-08-05 00:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 00:00:008-KStáhnout
2022-06-01 01:00:008-KStáhnout
2022-06-01 00:00:008-KStáhnout
2022-05-06 01:00:0010-QStáhnout
2022-05-06 00:00:0010-QStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 00:00:008-KStáhnout
2022-04-15 01:00:008-KStáhnout
2022-04-15 00:00:008-KStáhnout
2022-03-14 00:00:008-KStáhnout
2022-03-13 23:00:008-KStáhnout
2022-02-25 00:00:0010-KStáhnout
2022-02-24 23:00:0010-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-23 23:00:008-KStáhnout
2021-11-05 00:00:0010-QStáhnout
2021-11-04 23:00:0010-QStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-03 23:00:008-KStáhnout
2021-08-06 01:00:0010-QStáhnout
2021-08-06 00:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 00:00:008-KStáhnout
2021-07-22 01:00:008-KStáhnout
2021-07-22 00:00:008-KStáhnout
2021-07-20 01:00:008-KStáhnout
2021-07-20 00:00:008-KStáhnout
2021-05-28 01:00:008-KStáhnout
2021-05-28 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-07 01:00:0010-QStáhnout
2021-05-07 00:00:0010-QStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 00:00:008-KStáhnout
2021-02-26 00:00:0010-KStáhnout
2021-02-25 23:00:0010-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-24 23:00:008-KStáhnout
2020-11-23 00:00:008-KStáhnout
2020-11-22 23:00:008-KStáhnout
2020-11-06 00:00:0010-QStáhnout
2020-11-05 23:00:0010-QStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-04 23:00:008-KStáhnout
2020-09-11 01:00:008-KStáhnout
2020-09-11 00:00:008-KStáhnout
2020-08-07 01:00:0010-QStáhnout
2020-08-07 00:00:0010-QStáhnout
2020-08-05 01:00:008-KStáhnout
2020-08-05 00:00:008-KStáhnout
2020-06-03 01:00:008-KStáhnout
2020-06-03 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-08 01:00:0010-QStáhnout
2020-05-08 00:00:0010-QStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 00:00:008-KStáhnout
2020-04-16 01:00:008-KStáhnout
2020-04-16 00:00:008-KStáhnout
2020-04-13 01:00:008-KStáhnout
2020-04-13 00:00:008-KStáhnout
2020-03-12 00:00:008-KStáhnout
2020-03-11 23:00:008-KStáhnout
2020-03-02 00:00:0010-KStáhnout
2020-03-01 23:00:0010-KStáhnout
2020-02-26 00:00:008-KStáhnout
2020-02-25 23:00:008-KStáhnout
2019-11-08 00:00:0010-QStáhnout
2019-11-07 23:00:0010-QStáhnout
2019-11-06 00:00:008-KStáhnout
2019-11-05 23:00:008-KStáhnout
2019-10-17 01:00:008-KStáhnout
2019-10-17 00:00:008-KStáhnout
2019-10-10 01:00:008-KStáhnout
2019-10-10 00:00:008-KStáhnout
2019-09-24 01:00:008-KStáhnout
2019-09-24 00:00:008-KStáhnout
2019-09-16 01:00:008-KStáhnout
2019-09-16 00:00:008-KStáhnout
2019-08-21 01:00:008-KStáhnout
2019-08-21 00:00:008-KStáhnout
2019-08-09 01:00:0010-QStáhnout
2019-08-09 00:00:0010-QStáhnout
2019-08-07 01:00:008-KStáhnout
2019-08-07 00:00:008-KStáhnout
2019-05-21 01:00:008-KStáhnout
2019-05-21 00:00:008-KStáhnout
2019-05-10 01:00:0010-QStáhnout
2019-05-10 00:00:0010-QStáhnout
2019-05-09 01:00:008-KStáhnout
2019-05-09 00:00:008-KStáhnout
2019-04-29 01:00:008-KStáhnout
2019-04-29 00:00:008-KStáhnout
2019-04-18 01:00:008-KStáhnout
2019-04-18 00:00:008-KStáhnout
2019-03-15 00:00:0010-KStáhnout
2019-03-14 23:00:0010-KStáhnout
2019-03-12 00:00:008-KStáhnout
2019-03-11 23:00:008-KStáhnout
2019-01-25 00:00:008-KStáhnout
2019-01-24 23:00:008-KStáhnout
2019-01-08 00:00:008-KStáhnout
2019-01-07 23:00:008-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2018-11-09 00:00:0010-QStáhnout
2018-11-08 23:00:0010-QStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-07 23:00:008-KStáhnout
2018-09-12 01:00:008-KStáhnout
2018-09-12 00:00:008-KStáhnout
2018-08-09 01:00:0010-QStáhnout
2018-08-09 00:00:0010-QStáhnout
2018-08-08 01:00:008-KStáhnout
2018-08-08 00:00:008-KStáhnout
2018-07-31 01:00:008-KStáhnout
2018-07-31 00:00:008-KStáhnout
2018-07-13 01:00:008-KStáhnout
2018-07-13 00:00:008-KStáhnout
2018-06-27 01:00:008-KStáhnout
2018-06-27 00:00:008-KStáhnout
2018-05-22 01:00:008-KStáhnout
2018-05-22 00:00:008-KStáhnout
2018-05-10 01:00:0010-QStáhnout
2018-05-10 00:00:0010-QStáhnout
2018-05-08 01:00:008-KStáhnout
2018-05-08 00:00:008-KStáhnout
2018-03-15 00:00:0010-KStáhnout
2018-03-14 23:00:0010-KStáhnout
2018-03-13 00:00:008-KStáhnout
2018-03-12 23:00:008-KStáhnout
2017-11-08 23:00:0010-QStáhnout
2017-11-07 23:00:008-KStáhnout
2017-08-21 00:00:008-KStáhnout
2017-08-10 00:00:008-KStáhnout
2017-08-09 00:00:0010-QStáhnout
2017-08-08 00:00:008-KStáhnout
2017-07-11 00:00:008-KStáhnout
2017-05-26 00:00:008-KStáhnout
2017-05-10 00:00:0010-QStáhnout
2017-05-09 00:00:008-KStáhnout
2017-03-20 23:00:008-KStáhnout
2017-03-15 23:00:0010-KStáhnout
2017-03-06 23:00:008-KStáhnout
2017-02-02 23:00:008-KStáhnout
preloader